Covered recipient · General Payments record
ERIC C PETERSON
Allopathic & Osteopathic Physicians Neurological Surgery
General Payments · PY2018–2024
$10,198,712.21
- Reported across 394 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Acquisitions | $1,150,901.10 | 1 |
| Food and Beverage | $724.24 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,150,901.10 | 1 |
| Lilly USA, LLC | $204.30 | 2 |
| ABBVIE INC. | $171.83 | 5 |
| Balt USA, LLC | $171.36 | 2 |
| Janssen Biotech, Inc. | $136.74 | 6 |
| Penumbra, Inc. | $40.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.82 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105249205 | CMS |
| ABBVIE INC. | $29.99 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105249209 | CMS |
| ABBVIE INC. | $51.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105249213 | CMS |
| ABBVIE INC. | $24.60 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105249217 | CMS |
| ABBVIE INC. | $32.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105249221 | CMS |
| Balt USA, LLC | $149.94 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154347473 | CMS |
| Balt USA, LLC | $21.42 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154345459 | CMS |
| Janssen Biotech, Inc. | $9.09 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078447525 | CMS |
| Janssen Biotech, Inc. | $16.50 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078442775 | CMS |
| Janssen Biotech, Inc. | $28.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078442968 | CMS |
| Janssen Biotech, Inc. | $27.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078443107 | CMS |
| Janssen Biotech, Inc. | $21.79 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078445579 | CMS |
| Janssen Biotech, Inc. | $33.18 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078444758 | CMS |
| Lilly USA, LLC | $88.85 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967187 | CMS |
| Lilly USA, LLC | $115.45 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136166486 | CMS |
| Medtronic, Inc. | $1,150,901.10 | 08/07/2024 | Acquisitions | Undisputed | 01/23/2026 | 1112065682 | CMS |
| Penumbra, Inc. | $40.01 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076221650 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.